Navigation Links
Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Date:2/5/2008

g to this critical healthcare issue."

"Insmed is very much at the forefront of the evolving FOB industry," continued Dr. Allan. "We have the capacity and intellectual capital to successfully develop FOBs, and are determined to continue working diligently to ensure an effective regulatory pathway is established as soon as possible, and are prepared to enter the market as soon as this becomes a reality."

Insmed is currently developing a portfolio of FOBs and intends to initiate clinical trials for its first two FOBs in 2008. Members of Insmed's skilled biologics team have worked on over 50 therapeutic proteins. Their focused protein-based drug development backgrounds, coupled with the Company's FDA-approved protein manufacturing facility, and clinical and regulatory expertise, positions Insmed, upon the establishment of a regulatory pathway, to be an initial entrant into the U.S. FOBs market with a broad range of medicines following the expiration of patents covering the innovator products.

According to published reports, an estimated $10 billion worth of biologic drugs are expected to come off patent by 2010 (with an additional $10 billion by 2015). FOBs would provide safe and effective therapies at a reduced cost following the expiration of the original product's patent.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. Insmed has a state-of-the-art, FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a Corporate office in Richmond, Virginia. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cauti
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
2. Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
3. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
4. Hospital Launches Landmark Emergency Medicine Project
5. Watson Launches Generic Biaxin(R) XL
6. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
7. APIC Launches Targeting Zero Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS
8. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
9. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer for ... As a result of the waiver, the transaction is ... the tender offer on January 24, 2014 following the currently scheduled ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... 19 Celsion Corporation (Nasdaq: CLSN ... ThermoDox® High Intensity Focused Ultrasound (HIFU) development program ... MR-guided Focused Ultrasound 2010 2nd International Symposium.  The ... as the rationale and support for future clinical ...
... Therapeutics, Inc. (BMT, Inc.), a new Seoul-based RNAi ... reduce significantly deleterious side effects triggered by conventional ... operations. The company is currently developing a novel ... on its asymmetric shorter-duplex siRNA (asiRNA) technology, originally ...
Cached Medicine Technology:Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium 2Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium 3BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors 2BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors 3
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 16, 2014) The cause of neuronal death in ... proposes that neurons may be mistaken for foreign invaders ... to the way autoimmune diseases like type I diabetes, ... The study was published April 16, 2014, in ... likely controversial, idea in Parkinson,s disease; but if true, ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... The Hour-Long Special Narrated by Glenn Close Premieres November 18 at ... AM ... Nearly every society on earth is,affected by diabetes -- one of ... million people worldwide are,living with the disease, a number that is ...
... Fire Sabotage Is Latest Attack on Striking Nurses, ... 700,striking nurses at Appalachian Regional Health Care (ARH), ... American Nurses,AFL-CIO, are speaking out to call public ... them by the hospital during their strike,which began ...
... California youth have,teamed up with doctors, teachers, ... for announcing its intent to stop selling,Rockstar 21, ... on Alcopops and Youth is calling on Anheuser ... drinks to follow,Rockstar,s lead. Sold in brightly ...
... sure why mortality may be tied to weight , , MONDAY, ... much weight spells health problems, new research suggests that fat ... with prostate cancer than men of normal weight. , The ... higher risk of death from prostate cancer, and it,s not ...
... California San Francisco has identified distinct molecular markers that ... develop subsequent invasive cancer after initial diagnosis with a ... by Cell Press in the November issue of Cancer ... determine whether a woman should receive more or less ...
... and scientists,from around the world gathered for the ... Florida. The Symposium was,hosted by the Ringling Bros. ... the International Elephant Foundation (IEF), and was,held in ... Elephant,Tuberculosis Research. The Conference brought together experts in ...
Cached Medicine News:Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 2Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 3Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 4Health News:Nurses Protest Violent Tactics Against Picketers 2Health News:Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks 2Health News:Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks 3Health News:Obesity Linked to Prostate Cancer Death Rates 2Health News:Obesity Linked to Prostate Cancer Death Rates 3Health News:Biomarkers predict risk for invasive breast cancer years before the tumor develops 2Health News:Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation 2Health News:Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation 3Health News:Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation 4
... Oxyflo is a highly featured laser ... microvascular blood perfusion from multiple tissue ... developments in Digital Signal Processing (DSP) ... technologically advanced, yet simple to use, ...
... a highly featured laser doppler system ... perfusion from multiple tissue sites. This ... Digital Signal Processing (DSP) and laser ... yet simple to use, multi-channel monitor, ...
Transcranial vascular DWL doppler....
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Medicine Products: